CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.55
+0.03 (+6.81%)
Financial Highlights (FY 2026)
Revenue
20.64M
Net Income
-16,572,079
Gross Margin
99.5%
Profit Margin
-80.3%
Rev Growth
-2.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 20.64M 21.15M 3.13M 3.55M
Gross Profit 20.54M 21.05M 1.30M 1.47M
Operating Income -12,485,637 -11,514,574 -147,597 -160,008
Net Income -16,572,079 -15,283,196 -134,676 -196,009
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Rev Growth -2.4% -2.4% +0.4% +3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.19M 1.49M
Total Equity 5.82M 5.64M
D/E Ratio 0.21 0.27
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -16,572,079 -16,132,262 -218,349 -232,431
Free Cash Flow -122,296 -194,300